Announced Tue, 7 Jul · 16:57 IST
Routine quarterly compliance certificate filed under SEBI Reg 74(5)
Compliance View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹1363.50
prior close
₹1360.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1+2.1+3.3+2.5+4.0+3.7+5.2+7.1+8.5+2.8————
Up moveDown movePending
AI summary
Senores Pharmaceuticals filed a routine quarterly certificate under SEBI Regulation 74(5) for Q1 FY27 (quarter ended June 30, 2026). The certificate was submitted by MUFG Intime India, the company's Registrar and Share Transfer Agent, confirming that all securities received from depository participants for dematerialisation were properly processed and listed on the exchanges within prescribed timelines.
Likely market impact
Routine regulatory compliance filing with no material impact on shareholders or stock price.